- Home
- IMAB vs HGLB Comparison
IMAB vs HGLB Comparison
Compare IMAB & HGLB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMAB
- HGLB
- Stock Information
- Founded
- IMAB 2014
- HGLB 1998
- Country
- IMAB United States
- HGLB United States
- Employees
- IMAB N/A
- HGLB N/A
- Industry
- IMAB Biotechnology: Pharmaceutical Preparations
- HGLB Trusts Except Educational Religious and Charitable
- Sector
- IMAB Health Care
- HGLB Finance
- Exchange
- IMAB Nasdaq
- HGLB Nasdaq
- Market Cap
- IMAB 200.9M
- HGLB 198.2M
- IPO Year
- IMAB 2020
- HGLB N/A
- Fundamental
- Price
- IMAB $4.87
- HGLB $8.51
- Analyst Decision
- IMAB Strong Buy
- HGLB
- Analyst Count
- IMAB 3
- HGLB 0
- Target Price
- IMAB $6.33
- HGLB N/A
- AVG Volume (30 Days)
- IMAB 4.2M
- HGLB 91.8K
- Earning Date
- IMAB 05-15-2025
- HGLB 01-01-0001
- Dividend Yield
- IMAB N/A
- HGLB 13.16%
- EPS Growth
- IMAB N/A
- HGLB N/A
- EPS
- IMAB N/A
- HGLB N/A
- Revenue
- IMAB N/A
- HGLB N/A
- Revenue This Year
- IMAB N/A
- HGLB N/A
- Revenue Next Year
- IMAB N/A
- HGLB N/A
- P/E Ratio
- IMAB N/A
- HGLB N/A
- Revenue Growth
- IMAB N/A
- HGLB N/A
- 52 Week Low
- IMAB $0.60
- HGLB $6.42
- 52 Week High
- IMAB $5.90
- HGLB $9.45
- Technical
- Relative Strength Index (RSI)
- IMAB 75.47
- HGLB 56.96
- Support Level
- IMAB $3.30
- HGLB $8.23
- Resistance Level
- IMAB $3.94
- HGLB $8.43
- Average True Range (ATR)
- IMAB 0.58
- HGLB 0.17
- MACD
- IMAB 0.23
- HGLB 0.04
- Stochastic Oscillator
- IMAB 76.12
- HGLB 88.89
About IMAB I-MAB
I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).
About HGLB Highland Global Allocation Fund
Highland Global Allocation Fund is a diversified, closed-end management investment company. The investment objective of the Fund is to seek long-term growth of capital and future income. The Fund seeks to achieve its investment objectives by investing in a portfolio of U.S. and foreign equity, debt, and money market securities. It may also invest in senior loans to domestic or foreign corporations, partnerships, and other entities that operate in a variety of industries and geographic regions.